The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 03, 2021

Filed:

Nov. 02, 2018
Applicant:

Medimmune Limited, Cambridge, GB;

Inventors:

Andrew Buchanan, Cambridge, GB;

Matthieu Chodorge, Cambridge, GB;

Peter Cariuk, Cambridge, GB;

Johanna Husmark, Macclesfield, GB;

Clare Balendran, Molndal, SE;

Deepesh Pandey, Baltimore, MD (US);

Fumin Chang, Baltimore, MD (US);

Daniel E. Berkowitz, Baltimore, MD (US);

Lewis H. Romer, Baltimore, MD (US);

Assignee:

MedImmune Limited, Cambridge, GB;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 39/395 (2006.01); A61P 9/10 (2006.01); A61P 9/04 (2006.01); A61P 9/12 (2006.01); C12N 15/09 (2006.01); C12N 15/11 (2006.01); C12N 15/63 (2006.01); C07K 14/47 (2006.01); C12N 15/113 (2010.01); A61K 31/7068 (2006.01); A61K 39/00 (2006.01); C07K 16/30 (2006.01); C12N 5/00 (2006.01); C12N 5/095 (2010.01); G01N 33/00 (2006.01); G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2851 (2013.01); A61K 39/395 (2013.01); A61K 39/3955 (2013.01); A61P 9/04 (2018.01); A61P 9/10 (2018.01); A61P 9/12 (2018.01); C07K 16/28 (2013.01); C12N 15/09 (2013.01); C12N 15/11 (2013.01); C12N 15/63 (2013.01); A61K 31/7068 (2013.01); A61K 2039/505 (2013.01); C07K 14/47 (2013.01); C07K 16/30 (2013.01); C07K 2317/21 (2013.01); C07K 2317/33 (2013.01); C07K 2317/565 (2013.01); C07K 2317/622 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); C07K 2317/94 (2013.01); C07K 2318/00 (2013.01); C12N 5/00 (2013.01); C12N 5/0695 (2013.01); C12N 15/1138 (2013.01); C12N 2310/14 (2013.01); C12N 2310/531 (2013.01); C12N 2800/10 (2013.01); G01N 33/00 (2013.01); G01N 33/574 (2013.01);
Abstract

This disclosure provides LOX1 (LOX1) binding proteins such as anti-LOX1 antibodies, and compositions and methods for making these binding proteins. In certain aspects the LOX1-binding proteins provided herein, inhibit, or antagonize LOX1 activity. In addition, the disclosure provides compositions and methods for diagnosing and treating conditions associated with atherosclerosis, thrombosis, coronary artery disease (CAD), ischemia (e.g., myocardial ischemia), infarction (e.g., myocardial infarction), acute coronary syndrome (ACS), stroke, reperfusion injury, restenosis, peripheral vascular disease, hypertension, heart failure, inflammation (e.g., chronic inflammation), angiogenesis, preeclampsia, cancer and other LOX1-mediated diseases and conditions.


Find Patent Forward Citations

Loading…